Cyteir Therapeutics Inc
NASDAQ:CYT
Income Statement
Earnings Waterfall
Cyteir Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-34m
USD
|
Operating Income
|
-34m
USD
|
Other Expenses
|
740k
USD
|
Net Income
|
-33.2m
USD
|
Income Statement
Cyteir Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||
Operating Expenses |
(21)
|
(22)
|
(29)
|
(36)
|
(42)
|
(49)
|
(50)
|
(50)
|
(48)
|
(45)
|
(40)
|
(34)
|
|
Selling, General & Administrative |
(4)
|
(5)
|
(6)
|
(9)
|
(11)
|
(14)
|
(15)
|
(15)
|
(15)
|
(14)
|
(13)
|
(12)
|
|
Research & Development |
(17)
|
(17)
|
(23)
|
(27)
|
(31)
|
(35)
|
(35)
|
(35)
|
(34)
|
(31)
|
(27)
|
(22)
|
|
Operating Income |
(21)
N/A
|
(22)
-6%
|
(29)
-31%
|
(36)
-23%
|
(42)
-18%
|
(49)
-16%
|
(50)
-2%
|
(50)
0%
|
(48)
+4%
|
(45)
+6%
|
(40)
+11%
|
(34)
+16%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
4
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(4)
|
(4)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
0
|
0
|
|
Pre-Tax Income |
(21)
N/A
|
(22)
-7%
|
(29)
-31%
|
(36)
-23%
|
(42)
-18%
|
(49)
-16%
|
(50)
-2%
|
(49)
+1%
|
(46)
+6%
|
(44)
+3%
|
(41)
+8%
|
(33)
+18%
|
|
Net Income | |||||||||||||
Income from Continuing Operations |
(21)
|
(22)
|
(29)
|
(36)
|
(42)
|
(49)
|
(50)
|
(49)
|
(46)
|
(44)
|
(41)
|
(33)
|
|
Net Income (Common) |
(21)
N/A
|
(22)
-7%
|
(29)
-31%
|
(36)
-23%
|
(42)
-18%
|
(49)
-16%
|
(50)
-2%
|
(49)
+1%
|
(46)
+6%
|
(44)
+3%
|
(41)
+8%
|
(33)
+18%
|
|
EPS (Diluted) |
-0.6
N/A
|
-0.65
-8%
|
-0.85
-31%
|
-1.03
-21%
|
-1.2
-17%
|
-1.39
-16%
|
-1.4
-1%
|
-1.38
+1%
|
-1.31
+5%
|
-1.25
+5%
|
-1.15
+8%
|
-0.94
+18%
|